Hybrid imaging's promise for lymph node mapping in prostate cancer

03/19/2013 | MolecularImaging.net

Combining near-infrared fluorescence with hybrid imaging techniques such as PET/MR or SPECT/CT can help improve sentinel lymph node mapping ahead of and during surgery in patients with prostate cancer metastases, according to a study published in The Journal of Nuclear Medicine. The imaging methods, while still being assessed for their potential in the clinical setting, may in the future provide surgical teams with a means to improve prostate cancer staging, researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ